BPC 157 Banned: Key Facts on the Latest FDA Decision FDA removes Boxed Warning about risk of leg and foot amputations for the diabetes medicine canagliflozin (Invokana, Invokamet, Invokamet XR) FDA We have received an uptick in questions related to this substance. We felt it was best to share our policy here to bring attention to it. . OCB adheres to WADA guidelines Regulatory Alert: The Legal Status of BPC 157 in Compounding and Clinical Practice Holt Law The Pharmacology of Longevity: Peptide Edition (Part 1) Peptide Law: A Healthcare Attorney's Guide to the FD&C Act and Unapproved Drugs Holt Law